Antibodies against CD38 for treatment of multiple myeloma
US7829673B2 · kind B2 · utility
84Cited by
0References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2006 |
| Grant date | Nov 9, 2010 |
| Priority date | — |
| Expiry date | Aug 27, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/91148
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isolated human monoclonal antibodies which bind to human CD38, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.